Skip to main content
placeholder image

1058 A phase II evaluation of bone marrow protection by ethyol® (Amifostine)(Am) in patients with non-small cell lung cancer (NSCLC) treated with carboplatin(c)

Journal Article


Abstract


Publication Date


  • 1995

Citation


  • Betticher, D. C., Anderson, H., Ranson, M., Thatcher, N., Habboubi, N., & Meely, K. (1995). 1058 A phase II evaluation of bone marrow protection by ethyol® (Amifostine)(Am) in patients with non-small cell lung cancer (NSCLC) treated with carboplatin(c). European Journal of Cancer, 31, s221. doi:10.1016/0959-8049(95)96306-x

Web Of Science Accession Number


Start Page


  • s221

Volume


  • 31

Abstract


Publication Date


  • 1995

Citation


  • Betticher, D. C., Anderson, H., Ranson, M., Thatcher, N., Habboubi, N., & Meely, K. (1995). 1058 A phase II evaluation of bone marrow protection by ethyol® (Amifostine)(Am) in patients with non-small cell lung cancer (NSCLC) treated with carboplatin(c). European Journal of Cancer, 31, s221. doi:10.1016/0959-8049(95)96306-x

Web Of Science Accession Number


Start Page


  • s221

Volume


  • 31